Designed to detect the presence of the oncoprotein LMO2 (LIM-Only transcription factor 2, RBTN2, or TTG2), SensiStain Anti-LMO2 Antibody is in ready-to-use format. LMO2 has a role in angiogenesis and hematopoesis, and has been found to be expressed in erythroid and myeloid precursors, megakaryocytes, lymphoblastic and acute myeloid leukemia.